Core Viewpoint - Live Oak Bancshares, Inc. is under investigation for potential securities fraud and unlawful business practices following the announcement of material misclassifications in its financial statements [1][2]. Financial Reporting Issues - On November 12, 2025, Live Oak disclosed that it would amend its 2024 Annual Report and Quarterly Reports for the periods ended March 31, 2025, and June 30, 2025, to restate its Consolidated Financial Statements due to errors in cash flow classifications [2]. - The company identified a material weakness in its internal control over financial reporting, indicating that previous financial statements for the affected periods should no longer be relied upon [2]. Market Reaction - Following the announcement of the financial restatement, Live Oak's stock price decreased by $0.80, or 2.49%, closing at $31.29 per share on November 13, 2025 [2].

Core Insights - Bed Bath & Beyond (BBBY) reported a quarterly loss of $0.19 per share, outperforming the Zacks Consensus Estimate of a loss of $0.38, and showing improvement from a loss of $0.96 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company generated revenues of $257.19 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.45% and down from $311.43 million year-over-year [2] - The stock has increased approximately 73.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.5% [3] Earnings Outlook - The future performance of Bed Bath & Beyond's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.28 on revenues of $268 million, and for the current fiscal year, it is -$1.30 on revenues of $1.04 billion [7] Industry Context - The Internet - Commerce industry, to which Bed Bath & Beyond belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Market Overview - The pet industry in China is experiencing significant growth, with the market size projected to increase from 102.2 billion yuan in 2016 to 309.6 billion yuan by 2024, reflecting a compound annual growth rate (CAGR) of 21.6% from 2016 to 2020 and a projected CAGR of 7.6% from 2020 to 2025 [1][2] - The post-pandemic era has led to a stable growth trajectory for the pet market, with the number of pet cats and dogs returning to low single-digit growth rates [1][2] Segment Analysis - The pet cat market is growing faster than the dog market, with a projected market size of 300.2 billion yuan for both cats and dogs in 2024, and a CAGR of 9.9% from 2018 to 2024. The CAGR for pet cats is 14.3%, while for dogs it is 6.7% [2][3] - Pet food remains the core expenditure, accounting for 52.8% of overall spending on pets in 2024, with staple food having a penetration rate exceeding 95% [3][4] Consumer Trends - There is a noticeable shift in consumer preferences towards domestic brands, with an increase in acceptance of local pet food brands. The proportion of dog owners choosing domestic brands rose from 27.1% in 2023 to 32.9% in 2024, while cat owners' preference increased from 28.3% to 34.8% [6][7] - The demand for pet hygiene, care, and smart pet products is rapidly increasing, with the retail compound growth rate for pet grooming products projected at 10.9% from 2023 to 2025 [5][6] Export Market - The Southeast Asian pet market is experiencing explosive growth, with a pet ownership rate of 50%. Indonesia and Thailand are key markets, with pet industry sizes of approximately 3 billion and 2.29 billion USD, respectively [9] - China's pet food exports are on the rise, with export volumes expected to grow from 26.9 thousand tons in 2022 to 33.5 thousand tons in 2024, and export values increasing from 8.26 billion yuan to 10.53 billion yuan during the same period [9][10] Industry Players - Leading companies in the pet food sector include Guobao, Zhongchong, and others, with Guobao expected to surpass Mars in market share. The market is seeing a trend towards rational decision-making among consumers, favoring domestic brands [6][8] - Various companies are innovating in the pet care space, including those focusing on smart pet products and health care, such as Yiyuan, Yuanfei, and others [10][11]

Core Insights - JD.com, Inc. (JD) shares increased by 5.7% to $34.83, with a notable trading volume, outperforming its 3.6% gain over the past four weeks [1] - The company is experiencing growth due to strong supply chain capabilities, user growth, and synergies between its core retail and new business initiatives like food delivery [1] Earnings Expectations - JD.com is projected to report quarterly earnings of $0.44 per share, reflecting a year-over-year decline of 64.5%, while revenues are expected to reach $41.21 billion, an increase of 11.1% from the previous year [2] - The consensus EPS estimate for JD.com has remained stable over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] Industry Context - JD.com holds a Zacks Rank of 3 (Hold) within the Zacks Internet - Commerce industry, while another industry player, PetMed (PETS), has a Zacks Rank of 5 (Strong Sell) and has seen a decline of 12.8% over the past month [3][4]

Financial Performance - Chewy reported quarterly earnings of $0.33 per share, matching the Zacks Consensus Estimate, and an increase from $0.24 per share a year ago [1] - The company posted revenues of $3.1 billion for the quarter ended July 2025, exceeding the Zacks Consensus Estimate by 0.71% and up from $2.86 billion year-over-year [2] - Chewy has surpassed consensus EPS estimates two times in the last four quarters and topped consensus revenue estimates four times in the same period [1][2] Stock Performance - Chewy shares have increased approximately 25.7% since the beginning of the year, outperforming the S&P 500's gain of 10.7% [3] - The sustainability of the stock's price movement will depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $3.04 billion, and for the current fiscal year, it is $1.28 on revenues of $12.48 billion [7] - The estimate revisions trend for Chewy was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Internet - Commerce industry, to which Chewy belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, PetMed, is expected to report a quarterly loss of $0.06 per share, reflecting a year-over-year change of -133.3% [9]

Core Viewpoint - The pet economy has emerged as a resilient sector within the consumer market, attracting significant attention from public funds and investment institutions, indicating its long-term value despite economic fluctuations [1][4]. Group 1: Fund Holdings and Market Trends - As of June 2023, public funds have increased their holdings in leading pet economy stocks, with the proportion of holdings in Guibao Pet reaching 18.25%, and Zhongchong shares rising from 8.06% at the end of last year to 15.74% [1]. - The pet economy index has seen a growth of over 44% this year, with individual stocks like Zhejiang Zhengte increasing by over 90%, and others such as Source Fly Pet and Zhongchong shares rising over 60% [4][5]. Group 2: Financial Performance - In the first half of 2025, Guibao Pet, Zhongchong shares, and Lusi shares reported revenue growths of 32.72%, 24.32%, and 11.32% respectively, with net profits for Guibao Pet and Zhongchong shares increasing by 22.55% and 42.56% [5][6]. - The overall performance of the pet economy is attributed to a recovery in industry performance, with several listed companies seeking to capitalize on this emerging market [4]. Group 3: Investment Opportunities - The pet industry consists of various segments, including pet food, medical care, and supplies, but lacks a representative and stable index, making it challenging to track through ETFs [7]. - Active funds focusing on the pet economy, such as Zheshang Big Data Smart Selection Consumption and Fuguo Core Assets, have shown strong performance, with Fuguo Industry Driven A achieving a return of over 40% in the past year [8][9]. Group 4: Market Dynamics - The Chinese pet food market is transitioning from rapid growth to high-quality development, emphasizing the importance of brand competition, channel transformation, and consumer upgrades [9]. - Companies are encouraged to adapt to changing consumer demands, strengthen supply chains, and develop comprehensive channel ecosystems to gain a competitive edge in the pet economy [9].

Group 1 - Block & Leviton is investigating PetMed Express, Inc. for potential securities law violations following significant delays in financial reporting and executive resignations [1][2][4] - PetMed Express announced a delay in its 2025 fourth quarter and year-end financial results on June 10, 2025, and further delayed the filing due to an internal investigation into revenue recognition [2] - The company's stock price has fallen by almost 30% after the resignation of its CEO and CFO on August 12, 2025 [2] Group 2 - Investors who have lost money in PetMed Express may be eligible to recover losses and are encouraged to contact Block & Leviton for more information [3][5] - Block & Leviton is recognized as a leading securities class action firm, having recovered billions of dollars for defrauded investors [7] - Whistleblowers with non-public information about PetMed Express may assist in the investigation and could receive rewards of up to 30% of any successful recovery [6]

Core Insights - Etsy reported quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.54 per share, and down from $0.41 per share a year ago, representing an earnings surprise of -53.70% [1] - The company posted revenues of $672.66 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.80%, and up from $647.81 million year-over-year [2] - Etsy has outperformed the S&P 500, gaining about 14% since the beginning of the year compared to the S&P 500's gain of 8.3% [3] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $0.63 on revenues of $645.56 million, and for the current fiscal year, it is $1.80 on revenues of $2.79 billion [7] - The estimate revisions trend for Etsy was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Internet - Commerce industry, to which Etsy belongs, is currently in the bottom 41% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of Etsy's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Points - PetMed Express, Inc. will ring the Nasdaq Opening Bell on April 11, 2025, in celebration of National Pet Day, highlighting the bond between people and their pets [1][2] - The event will feature adoptable rescue dogs from Bidawee, emphasizing the importance of pet adoption and the joy pets bring to families [2][3] - Sandra Campos, President & CEO of PetMeds, advocates for accessible preventative healthcare for pets and supports rescue efforts across the country [3] Company Overview - Founded in 1996, PetMed Express, Inc. is a leader in the consumer pet healthcare sector, providing a wide range of pet health products through its online platforms [5] - The company offers prescription medications, vet-recommended food, and supplies, aiming to enhance the wellness and longevity of pets [5] - PetMeds operates with expert pharmacists and licenses across fifty states, ensuring a comprehensive service for pet owners [5]

Core Insights - PetMed Express, Inc. has appointed Peter Batushansky to its Board of Directors, effective April 09, 2025, marking the third independent director added since 2024 [1][2] - Dr. Gian Fulgoni, a longtime board member and former Chairman, will retire at the 2025 annual shareholders' meeting [1][2] - The company is undergoing a leadership transformation, with recent appointments including Leslie C. G. Campbell as Chairman and Sandra Campos as CEO [2][3] Company Strategy and Leadership - The addition of Mr. Batushansky is part of the company's strategy to enhance board composition and support its transformation plan aimed at driving shareholder value [2][3] - The board will consist of seven directors, six of whom are independent, with three new members added since 2024 [2] - Mr. Batushansky's experience in retail, pet, and healthcare sectors is expected to align with the company's ambitions to expand its business in the pet wellness ecosystem [3][4] Background of New Board Member - Mr. Batushansky has over 20 years of experience in various industries, including roles as CEO of Allivet and WebEyeCare [4][5] - Currently, he is a Partner at L2 Capital Partners, contributing to his extensive background in private equity [5][6] Company Overview - PetMed Express, founded in 1996, is a leader in the consumer pet healthcare sector, operating as a national online retailer [7] - The company offers a range of pet health products, including pharmaceuticals and supplements, through its websites [7]